Outcomes of Coronary Stenoses Deferred Revascularization for Borderline Versus Nonborderline Fractional Flow Reserve Values

被引:21
作者
Depta, Jeremiah P. [1 ]
Patel, Jayendrakumar S. [1 ]
Novak, Eric [1 ]
Masrani, Shriti K. [1 ]
Raymer, David [1 ]
Facey, Gabrielle [1 ]
Patel, Yogesh [1 ]
Zajarias, Alan [1 ]
Lasala, John M. [1 ]
Singh, Jasvindar [1 ]
Bach, Richard G. [1 ]
Kurz, Howard I. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Med, Div Cardiol, St Louis, MO 63110 USA
关键词
INTRAVENOUS ADENOSINE; FOLLOW-UP; MYOCARDIAL-INFARCTION; PROGNOSTIC VALUE; ARTERY STENOSES; MEDICAL THERAPY; BLOOD-FLOW; INTERVENTION; INTRACORONARY; DISEASE;
D O I
10.1016/j.amjcard.2014.03.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Current evidence supports deferral of revascularization for lesions with fractional flow reserve (FFR) values >0.80. The natural history after deferral of revascularization of lesions with borderline FFR values is unknown. This study evaluated the outcomes of patients after deferred revascularization of coronary stenoses based on a borderline FFR value. We retrospectively studied 720 patients with 881 intermediate-severity coronary stenoses who underwent FFR assessment from October 2002 to July 2010 and were deferred revascularization. Patients were divided into gray zone (0.75 to 0.80), borderline (0.81 to 0.85), and nonborderline (>0.85) FFR groups. Any subsequent percutaneous coronary intervention or coronary artery bypass grafting of a deferred stenosis during follow-up was classified as a deferred lesion intervention (DLI). Patient and/or lesion characteristics and clinical outcomes were compared between the FFR groups using univariate and propensity score-adjusted inverse probability of weighting Cox proportional hazards analyses. During a mean follow-up of 4.5 +/- 2.1 years, 157 deferred lesions (18%) underwent DLI by percutaneous coronary intervention (n = 117) or coronary artery bypass grafting (n = 40). No statistically significant differences were observed in clinical outcomes between the gray zone and borderline FFR groups. Lesions with a borderline FFR were associated with a significantly higher risk of DLI compared with lesions with nonborderline FFR values (hazard ratio 1.63, 95% confidence interval 1.14 to 2.33, p = 0.007). Lesions deferred revascularization because of a borderline FFR (0.81 to 0.85) were associated with a higher risk of DLI compared with lesions with a nonborderline FFR (>0.85). Further study is needed to determine the optimal management of coronary stenoses with a borderline FFR value. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:1788 / 1793
页数:6
相关论文
共 27 条
[1]   Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis - A randomized trial [J].
Bech, GJW ;
De Bruyne, S ;
Pijls, NHJ ;
de Muinck, ED ;
Hoorntje, JC ;
Escaned, J ;
Stella, PR ;
Boersma, E ;
Bartunek, J ;
Koolen, JJ ;
Wijns, W .
CIRCULATION, 2001, 103 (24) :2928-2934
[2]   Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement [J].
Bech, GJW ;
De Bruyne, B ;
Bonnier, HJRM ;
Bartunek, J ;
Wijns, W ;
Peels, K ;
Heyndrickx, GR ;
Koolen, JJ ;
Pijls, NHJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (04) :841-847
[3]   Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease [J].
Berger, A ;
Botman, KJ ;
MacCarthy, PA ;
Wijns, W ;
Bartunek, J ;
Heyndrickx, GR ;
Pijls, NHJ ;
De Bruyne, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (03) :438-442
[4]   Optimal medical therapy with or without PCI for stable coronary disease [J].
Boden, William E. ;
O'Rourke, Robert A. ;
Teo, Koon K. ;
Hartigan, Pamela M. ;
Maron, David J. ;
Kostuk, William J. ;
Knudtson, Merril ;
Dada, Marcin ;
Casperson, Paul ;
Harris, Crystal L. ;
Chaitman, Bernard R. ;
Shaw, Leslee ;
Gosselin, Gilbert ;
Nawaz, Shah ;
Title, Lawrence M. ;
Gau, Gerald ;
Blaustein, Alvin S. ;
Booth, David C. ;
Bates, Eric R. ;
Spertus, John A. ;
Berman, Daniel S. ;
Mancini, G. B. John ;
Weintraub, William S. ;
Boden, W. ;
O'Rourke, R. ;
Teo, K. ;
Hartigan, P. ;
Weintraub, W. ;
Maron, D. ;
Mancini, J. ;
Weintraub, W. ;
Boden, W. ;
O'Rourke, R. ;
Teo, K. ;
Hartigan, P. ;
Knudtson, M. ;
Maron, D. ;
Bates, E. ;
Blaustein, A. ;
Booth, D. ;
Carere, R. ;
Ellis, S. ;
Gosselin, G. ;
Gau, G. ;
Jacobs, A. ;
King, S., III ;
Kostuk, W. ;
Harris, C. ;
Spertus, J. ;
Peduzzi, P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (15) :1503-1516
[5]   PROGNOSTIC VALUE OF A CORONARY-ARTERY JEOPARDY SCORE [J].
CALIFF, RM ;
PHILLIPS, HR ;
HINDMAN, MC ;
MARK, DB ;
LEE, KL ;
BEHAR, VS ;
JOHNSON, RA ;
PRYOR, DB ;
ROSATI, RA ;
WAGNER, GS ;
HARRELL, FE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (05) :1055-1063
[6]   Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? [J].
Casella, G ;
Leibig, M ;
Schiele, TM ;
Schrepf, R ;
Seelig, V ;
Stempfle, HU ;
Erdin, P ;
Rieber, J ;
König, A ;
Siebert, U ;
Klauss, V .
AMERICAN HEART JOURNAL, 2004, 148 (04) :590-595
[7]   Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements [J].
Courtis, Javier ;
Rodes-Cabau, Josep ;
Larose, Eric ;
Dery, Jean-Pierre ;
Nguyen, Can Manh ;
Proulx, Guy ;
Gleeton, Onil ;
Roy, Louis ;
Barbeau, Gerald ;
Noel, Bernard ;
DeLarochelliere, Robert ;
Bertrand, Olivier F. .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2008, 71 (04) :541-548
[8]   Usefulness of Coronary Fractional Flow Reserve Measurements in Guiding Clinical Decisions in Intermediate or Equivocal Left Main Coronary Stenoses [J].
Courtis, Javier ;
Rodes-Cabau, Josep ;
Larose, Eric ;
Potvin, Jean-Michel ;
Dery, Jean-Pierre ;
De Larochelliere, Robert ;
Cote, Melanie ;
Cousterousse, Olivier ;
Nguyen, Can M. ;
Proulx, Guy ;
Rinfret, Stephane ;
Bertrand, Olivier F. .
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (07) :943-949
[9]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[10]   Intracoronary and intravenous adenosine 5′-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans [J].
De Bruyne, B ;
Pijls, NHJ ;
Barbato, E ;
Bartunek, J ;
Bech, JW ;
Wijns, W ;
Heyndrickx, GR .
CIRCULATION, 2003, 107 (14) :1877-1883